Home - Products - Angiogenesis - EGFR - 7,8-Dihydroxyflavone

7,8-Dihydroxyflavone

CAS No. 38183-03-8

7,8-Dihydroxyflavone ( 7,8-Dihydroxyflavone; DHF )

Catalog No. M18494 CAS No. 38183-03-8

7, 8-Dihydroxyflavone (7, 8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves.

Purity : 98%

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
10MG	27	Get Quote
50MG	61	Get Quote
100MG	81	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

7,8-Dihydroxyflavone
Note

Research use only, not for human use.
Brief Description

7, 8-Dihydroxyflavone (7, 8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves.
Description

7,8-Dihydroxyflavone is an agonist of tyrosine receptor kinase B (TrkB). It acts by promoting immature neuron survival after TBI through activation of the BDNF signaling pathway.
Synonyms

7,8-Dihydroxyflavone; DHF
Pathway

Angiogenesis
Target

EGFR
Recptor

TrkB
Research Area

Metabolic Disease|Neurological Disease
Indication

——

Chemical Information

CAS Number

38183-03-8
Formula Weight

254.24
Molecular Formula

C15H10O4
Purity

98%
Solubility

DMSO : ≥ 100 mg/mL; 393.33 mM
SMILES

c1ccc(cc1)c1cc(=O)c2c(o1)c(c(cc2)O)O
Chemical Name

7,8-Dihydroxy-2-phenyl-chromen-4-one

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Lee RH, et al. Oncol Rep. 2015 Feb;33(2):631-8.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Canertinib dihydroch...

A potent, irreversible, orally available pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 7.5 nM and 9.0 nM in autophosphorylation assay.
CGP77675

CGP77675 is a potent and selective inhibitor of Src family kinase with IC50s of 5-20 and 40 nM for the phosphorylation of peptide substrates and autophosphorylation of purified Src. CGP77675 exhibits anticancer activity.
Nimotuzumab

Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).

Sign In Join Free